Posts

Showing posts from June, 2026

Empowering Families Living with Type 1 Diabetes

Image
Group photo, 20 June Diabetes Workshop When a child or young person is diagnosed with type 1 diabetes, the diagnosis often comes with uncertainty, fear, and countless questions. Understanding the condition, learning essential self-management skills, and finding a supportive community can make all the difference in transforming that fear into confidence. With this vision in mind, Sally Mugabe Children's Hospital and Parirenyatwa Group of Hospitals Diabetes Clinics successfully hosted a comprehensive Type 1 Diabetes Education Workshop on 20 June 2026 at the UNICEF Zimbabwe Offices in Harare. Designed primarily for newly diagnosed individuals living with type 1 diabetes and those who had not previously attended structured diabetes education, the workshop brought together approximately 80 participants, including children, adolescents, young adults living with diabetes, parents, caregivers, and family members. They were supported by a multidisciplinary team of 15 facilitators, comprisin...

Inside Sanofi’s Insulin Manufacturing Campus

Image
Group Photo: Members from LMICs: Nov 2025 I had the rare privilege of touring Sanofi’s Insulin Manufacturing Site in Frankfurt, Germany—an immense industrial campus located within the historic Industrie park Höchst. Organized by the Sanofi's Global Health Unit (GHU), the visit offered an extraordinary behind-the-scenes view of how insulin is engineered, produced, assembled, tested, packaged, and shipped to over one hundred countries around the world. This was not simply a factory tour. It was an immersive exploration into a century of insulin innovation, a sophisticated manufacturing ecosystem, and the evolving global strategy intended to expand access to life-saving diabetes medicines—especially for low- and middle-income countries. Inside The Insulin Manufacturing Plant Below are my reflections, insights, and key takeaways. I share them not just as a visitor, but as a person living with type 1 diabetes, an advocate for access, and a representative of communities that still strugg...